Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04292210 Completed - Renal Failure Clinical Trials

Human Factors Validation Testing for the Peripal System; a Manual Connection Assist Device for Peritoneal Dialysis Devices

Start date: February 19, 2018
Phase: N/A
Study type: Interventional

It is estimated that there are currently over 3 million patients receiving dialysis treatment worldwide. With effective pre-dialysis counselling, a majority of patients choose the home-based therapy peritoneal dialysis (PD) but only approximately 11% of prevalent dialysis patients use this modality. Connection-assist devices can overcome the challenges posed by decreased manual dexterity and/or visual acuity, and can allow more patients to be treated with home-based therapies. As part of the CE marking authorization, a connection device has been evaluated for safety and ease of use in a usability study.

NCT ID: NCT04291508 Completed - Sepsis Clinical Trials

Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery

ASTER
Start date: October 13, 2021
Phase: Phase 2
Study type: Interventional

Prospective multi-center phase 2b randomized placebo-controlled double-blinded interventional platform trial of two different pharmacologic therapies (intravenous Vitamin C or intravenous Acetaminophen) for patients with sepsis-induced hypotension or respiratory failure.

NCT ID: NCT04291443 Completed - Clinical trials for Orthodontic Appliance Complication

Proteomics and Orthodontic Root Resorption

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The majority of previous studies for early detection of Orthodontically Induced Inflammatory Root Resorption (OIIRR) were conducted to assess individual biomarkers which are representative of single biological pathway. To our Knowledge, no studies have been employed Gingival crevicular fluid (GCF) proteomic analysis to identify potential biomarkers for OIIRR. Therefore; the aim of this study is to use the advantage of testing a package of biomarkers via doing proteomic analysis of GCF which could help in making a more precise personalize diagnosis and treatments, thereby providing orthodontists additional information that cannot be deduced from clinical parameters.

NCT ID: NCT04291339 Completed - Clinical trials for Adult Patients 20 Years of Age or Older Who Are Planning to Undergo Surgery Under General Anesthesia

Comparison of the Efficacy of High-flow Nasal Oxygen Therapy and Facial Mask Ventilation on the Increase of the Oxygen Reserve Index During Anesthetic Induction

Start date: November 11, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the ability of oxygenation with high-flow nasal oxygen therapy and mask ventilation technique for induction of anesthesia in adult patients who are planning to undergo surgery under general anesthesia.

NCT ID: NCT04291274 Completed - Clinical trials for Long Term Neurobehavioral Effects

The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment(Retrospective Research)

Start date: November 1, 2019
Phase:
Study type: Observational

The long-term effect of general anesthesia on developing brain is the focus of clinicians when infants exposed to general anesthesia for a long time during operation. A retrospective study showed that children exposed to long-term or repeated operations, the anesthetics had a higher incidence of cognitive impairment in adolescence than those did no. When infants with hearing impairment undergo bilateral cochlear implant surgery, they are at high risk of long-term neurobehavioral abnormalities caused by anesthesia. In this study, investigators intend to observe the long-term behavioral abnormalities of hearing-impaired infants after intravenous or inhalation anesthesia by a ambispective cohort study.

NCT ID: NCT04290923 Completed - Clinical trials for Leukemia, Lymphocytic, Chronic, B-Cell

Determination of Blood Tumor Cells

Start date: October 1, 2017
Phase:
Study type: Observational

Magnetic nanoparticles coated with anti-EpCAM or anti-CD52 antibodies will be tested ex-vivo in patients blood .

NCT ID: NCT04290598 Completed - Clinical trials for Color; Change Teeth, Posteruptive

Clinical Effects of Dehydration on Tooth Colour

Start date: October 14, 2019
Phase:
Study type: Observational

Dental restorations should mimic sound tooth structures in terms of color and optical properties especially in the anterior region. However, closely matching natural teeth with a restoration can be one of the most challenging procedure in restorative dentistry. Shade matching includes color determination, color communication with dental lab and color reproduction with dental restoration for indirect techniques or color determination and selection of the appropriate material and application method when using direct techniques. Therefore color selection is the first critical step in the restoration procedures and should be carried out properly. Color determination must be carried out before any of the restorative procedures, isolation or impression. Most of the dental procedures cause dehydration and increase the opacity of the enamel and teeth appear whiter. Few clinical and in vitro studies evaluated the degree of color change after dehydration and rehydration periods. However, inconsistencies exist between studies in terms of color change degree and duration of return to appreciable values. The aim of the present study was to evaluate the degree of color change in half an hour dehydration period of the teeth and to determine if color return to baseline after half an hour or 24 hours. According to the null hypotheses of the study: - There is no perceptible difference occur after tooth dehydration. - Tooth color will not return to baseline values after half an hour or 24 hours rehydration periods.

NCT ID: NCT04290481 Completed - High Altitude Clinical Trials

Oxygen Saturation and Perfusion Index ın Neonates at High Altitude

Start date: June 1, 2018
Phase:
Study type: Observational

Congenital heart diseases are among the most common congenital anomalies and occur with an incidence of approximately 8ınd12 / 1,000 live births worldwide. This figure does not cover minor lesions such as bicuspid aortic valves and small atrial or ventricular septal defects. Most of these defects do not need treatment or treatment is needed after infancy. Other defects are severe and usually require early treatment in the neonatal period. Critical congenital heart disease is defined as structural heart defects that are associated with hypoxia in the neonatal period and have significant morbidity and mortality potential in early life. Critical congenital heart disease is estimated to be ~3 in 1000 live births. It is estimated that 50% of congenital heart diseases are detected by prenatal ultrasound. Even if a standard neonatal examination is performed, 13 to 55% of patients with critical congenital heart disease can be discharged from the hospital without being diagnosed. Screening of infants with non-invasive oxygen saturation measurement has been proposed as an adjunct to early detection of critical congenital heart disease. The American Academy of Pediatrics, the American Cardiology Foundation and the American Heart Association have targeted 7 specific lesions for the pulse oximetry screening protocol: truncus arteriosus, transposition of the great arteries, tricuspid atresia, tetralogy of Fallot, total pulmonary venous return anomaly, hypoplastic left heart syndrome and pulmonary atresia. The reference values of peripheral perfusion (PPI) index has been established for normal newborns between 1 and 120 h of age. Lower PPI values than 0.70 may indicate illness. Including cut-off values for PPI in pulse-oximetry screening for duct dependent congenital heart disease is a promising tool for improving the detection of critical congenital heart disease with duct-dependent systemic circulation. We aimed to investigate screening critical congenital heart disease and also to establish normal values of oxygen saturation and perfusion index at high altitude.

NCT ID: NCT04290247 Completed - Clinical trials for Pediatric Fracture Diagnosis by Ultrasound Compared to X-ray

Non-inferiority of Ultrasound for the Diagnosis of Upper Extremity Fractures in Children

FRUSKI
Start date: May 12, 2020
Phase: N/A
Study type: Interventional

This study evaluates the sensitivity of Ultrasound for Diagnostic of Fractures of the upper extremity compared to conventional x-ray in Children 0-18.

NCT ID: NCT04290039 Completed - Clinical trials for Toxic Effect of Organophosphate and Carbamate Insecticides

Sublingual vs IV Atropine Bioavailability Study

Start date: January 4, 2020
Phase: Phase 1
Study type: Interventional

This randomized, three-sequence, three-period, phase 1 study is designed to assess the bioavailability and pharmacokinetics (PK) of sublingually administered atropine sulfate ophthalmic solution 1% USP (at 0.5 mg and 1.0 mg; test) compared to atropine sulfate injection administered IV (1.0 mg; reference).